You are here

Entheon Biomedical Corp.

Entheon Biomedical Corp.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
ENBI
CSE Index: 
Currency: 

Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders. 

You are here

Entheon Biomedical Corp. (ENBI)

SEDAR Information

Company Info

Address
Suite 720-999 W Broadway Street
Vancouver, BC V5Z 1K5
Canada
Phone
604-562-3932
Email
info@entheonbiomedical.com
Website
https://entheonbiomedical.com/
Listing date
Thursday, May 3, 2018
Transfer Agent
Olympia Trust Company
Auditor
Manning Elliott LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
59,089,266
Reserved for Issuance: 
4,275,000

Company Officers

Timothy Ko, CEO
Soo-Whan Kim, Interim CFO
Kelly Pladson, Corporate Secretary
Andrew Hegle, Chief Science Officer

Bulletins

11/11/2020

2020-1111 – Fundamental Change - MPV Explorations Inc./Entheon Biomedical Corp.

le 11 novembre/November 2020

Entheon Biomedical Corp., the issuer resulting from a Fundamental Change of MPV Explorations Inc. (MPV), has been approved for listing.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

Benzinga Cannabis Capital Conference

Benzinga Cannabis Capital Conference

Tuesday, April 11, 2023 - 8:00am to Wednesday, April 12, 2023 - 5:00pm